Calidi Biotherapeutics, Inc. (CLDI)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch CLDI
Latest sale
$1k
Dec 12 · No plan
Form 4 sales
3
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 salePlan not stated
    Oct 19 2022

    Sold 36,200 shares at $9.90 ($358k)

    Polar Asset Management Partners Inc., 10% owner

    Sold 8.1% of holdings ($4.4M position)412,800 shares leftFirst sale on recordFiling

  2. 2 Form 4 saleNo plan
    Dec 17 +790 days

    Sold 10,000 shares at $1.62 ($16k)

    Camaisa Allan, CEO and Chairman of the Board

    No 10b5-1 planSold 13% of holdings ($124k position)66,712 shares leftFirst sale on recordFiling

  3. 3 Form 4 saleNo plan
    Dec 12 +360 days

    Sold 850 shares at $1.46 ($1k)

    Camaisa Allan, Director

    No 10b5-1 planSold 1.1% of holdings ($114k position)76,952 shares leftFiling

Every transaction

Loading transactions…

Sales, notices and lockups (3)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for CLDI
Source
Dec 12, 2025Camaisa AllanDirectorForm 4 sale850$1k1.1%No planSEC
Dec 17, 2024Camaisa AllanCEO and Chairman of the BoardForm 4 sale10,000$16k13.0%No planSEC
Oct 19, 2022Polar Asset Management Partners Inc.10% ownerForm 4 sale36,200$358k8.1%Plan not statedSEC